Treatment of Multidrug-resistant Tuberculosis
Editors in Conversation
Feb 9
40 min 16 sec
Tuberculosis is one of the most deadly infectious diseases that still causes significant burden of disease, particularly in the developing world.
The emergence of resistance to first line agents severely limits the therapeutic options and threaten the ability to control dissemination of this disease. Fortunately, new drugs and regimens are now emerging as important alternatives against these organisms.